These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 19763139)

  • 21. Purinergic receptors and their activation by endogenous purines at perisynaptic glial cells of the frog neuromuscular junction.
    Robitaille R
    J Neurosci; 1995 Nov; 15(11):7121-31. PubMed ID: 7472466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine receptor signaling: a key to opening the blood-brain door.
    Bynoe MS; Viret C; Yan A; Kim DG
    Fluids Barriers CNS; 2015 Sep; 12():20. PubMed ID: 26330053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purine nucleosides in neuroregeneration and neuroprotection.
    Ribeiro FF; Xapelli S; Miranda-Lourenço C; Tanqueiro SR; Fonseca-Gomes J; Diógenes MJ; Ribeiro JA; Sebastião AM
    Neuropharmacology; 2016 May; 104():226-42. PubMed ID: 26577017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purinoceptors on neuroglia.
    Verkhratsky A; Krishtal OA; Burnstock G
    Mol Neurobiol; 2009 Jun; 39(3):190-208. PubMed ID: 19283516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous adenosine protects CA1 neurons from kainic acid-induced neuronal cell loss in the rat hippocampus.
    Matsuoka Y; Okazaki M; Takata K; Kitamura Y; Ohta S; Sekino Y; Taniguchi T
    Eur J Neurosci; 1999 Oct; 11(10):3617-25. PubMed ID: 10564369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.
    Olsen AL; Feany MB
    Glia; 2019 Oct; 67(10):1933-1957. PubMed ID: 31267577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glial cells under physiologic and pathologic conditions.
    Kurosinski P; Götz J
    Arch Neurol; 2002 Oct; 59(10):1524-8. PubMed ID: 12374489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine transporters and receptors: key elements for retinal function and neuroprotection.
    Dos Santos-Rodrigues A; Pereira MR; Brito R; de Oliveira NA; Paes-de-Carvalho R
    Vitam Horm; 2015; 98():487-523. PubMed ID: 25817878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic examination of the neuroglial secretome: lessons for the clinic.
    Kim JH; Afridi R; Lee WH; Suk K
    Expert Rev Proteomics; 2020 Mar; 17(3):207-220. PubMed ID: 32187501
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of glial membrane ion channels in seizures and epileptogenesis.
    D'Ambrosio R
    Pharmacol Ther; 2004 Aug; 103(2):95-108. PubMed ID: 15369678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutamate-mediated glial injury: mechanisms and clinical importance.
    Matute C; Domercq M; Sánchez-Gómez MV
    Glia; 2006 Jan; 53(2):212-24. PubMed ID: 16206168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
    Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
    Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticonvulsant A(1) receptor-mediated adenosine action on neuronal networks in the brainstem-spinal cord of newborn rats.
    Brockhaus J; Ballanyi K
    Neuroscience; 2000; 96(2):359-71. PubMed ID: 10683576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine receptor signaling in the brain immune system.
    Haskó G; Pacher P; Vizi ES; Illes P
    Trends Pharmacol Sci; 2005 Oct; 26(10):511-6. PubMed ID: 16125796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purinergic signaling in kidney disease.
    Menzies RI; Tam FW; Unwin RJ; Bailey MA
    Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuroprotective mechanisms of adenosine action on CNS neurons].
    Zalewska-Kaszubska J
    Neurol Neurochir Pol; 2002; 36(2):329-36. PubMed ID: 12046508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trophic effects of purines in neurons and glial cells.
    Rathbone MP; Middlemiss PJ; Gysbers JW; Andrew C; Herman MA; Reed JK; Ciccarelli R; Di Iorio P; Caciagli F
    Prog Neurobiol; 1999 Dec; 59(6):663-90. PubMed ID: 10845757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuron-glia crosstalk gets serious: role in pain hypersensitivity.
    Ren K; Dubner R
    Curr Opin Anaesthesiol; 2008 Oct; 21(5):570-9. PubMed ID: 18784481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17.
    Fumagalli M; Lecca D; Abbracchio MP
    Neuropharmacology; 2016 May; 104():82-93. PubMed ID: 26453964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unravelling adenosine's effects on stroke.
    Fricker J
    Mol Med Today; 2000 Feb; 6(2):48. PubMed ID: 10652476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.